On June 6, 2014, the Judicial Panel on Multi-District Litigation granted a petition filed by Ron Johnson and Sarah Lynch, attorneys at Schachter, Hendy & Johnson, P.S.C., and ordered that all testosterone cases be coordinated in front of Judge Kennelly in the Northern District of Illinois. Prior to the request, Judge Kennelly presided over all AndroGel cases filed in the Northern District of Illinois, where Abbott and AbbVie, the makers of AndroGel, are headquartered.
As a result of this order, all testosterone cases filed in federal court will be transferred to Judge Kennelly in the Northern District of Illinois for coordination until the time of trial. This type of coordination is extremely helpful for all of the following reasons:
- It reduces the risk of conflicting rulings. Many of the underlying questions in this litigation (including whether there is sufficient evidence that testosterone can cause strokes, blood clots and heart attacks) will not vary from case to case.
- It increases efficiency.
- It decreases the costs of litigation. Parties are able to spread out the costs of litigation across a wider pool of clients / cases and thus reduce the cost of litigation.
The testosterone attorneys at Schachter, Hendy & Johnson are currently working along with other attorneys across the country on reviewing documents, talking with employees of the pharmaceutical companies involved and otherwise preparing for trial. The first AndroGel trial is scheduled to happen in the Fall of 2016. Judge Kennelly holds monthly conferences to address any issues that arise and ensure that the cases are proceeding in a timely fashion.
If you or a loved one had a stroke, pulmonary embolism, heart attack, deep vein thrombosis or blood clot while taking AndroGel or another form of testosterone, please call our experienced AndroGel attorneys at (888) 606-5297 for a free consultation about your potential AndroGel lawsuit.